Diabetes Mellitus (DM) Completed Phase 4 Trials for Insulin glargine (DB00047)

Also known as: Diabetes Mellitus / Mellitus Diabetes / Diabetus Mellitus / Diabetes Mellitus (D003920) / Diabetes Mellitis / Diabetes mellitus (E08-E13) / Diabetes mellitus NOS / Diabetes

IndicationStatusPhase
DBCOND0063084 (Diabetes Mellitus (DM))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01240200Satisfaction of Treatment Among Elderly Patients With Insulin TherapyTreatment
NCT02706119Insulin in Total Parenteral NutritionScreening
NCT00322075LANCGMS - Lantus Continuous Glucose Monitoring SubcutaneousTreatment
NCT00642915Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)Treatment
NCT00576368An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical PracticeTreatment
NCT00576862Extension to Study HMR1964A/3011 in BelgiumTreatment
NCT00609895The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning DosingTreatment
NCT00540709PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+LisproTreatment
NCT00565162Insulin Glargine, INITIATE Metabolic and Economic Outcomes of LantusTreatment